iPS Cells for Regenerative Medicine CiRA International Symposium

Transcription

Second Announcement
The 18th Takeda Science Foundation
Symposium on Bioscience
iPS Cells for
Regenerative Medicine
2015.1.15 -17
Takeda Science Foundation
3-6 Doshomachi, 2-chome, Chuo-ku
Osaka 541-0045, Japan
Phone: +81-6-6233-6101
Fax: +81-6-6233-6112
http://www.takeda-sci.or.jp
CiRA International
Symposium
2015.1.16
Center for iPS Cell
Research and Application (CiRA)
Kyoto University
53 Kawahara-cho, Shogoin, Sakyo-ku
Kyoto 606-8507, Japan
http://www.cira.kyoto-u.ac.jp
Secretariat
c/o Congress Corporation
Phone: +81-6-6292-6048
Fax: +81-6-6292-6066
E-mail: [email protected]
http://www.takeda-sci.com
Site: Center for Learning and Innovation
Takeda Pharmaceutical Company, Ltd.
iPS Cells for
Regenerative Medicine
2015.1.15 -17
CiRA International
Symposium
2015.1.16
DIC:654
The 18th Takeda Science Foundation Symposium on Bioscience
CiRA International Symposium
Invitation
Dear Colleagues,
Induced pluripotent stem cell (iPSC) technology has opened the
door to a new field of cell reprogramming that allows scientists to
convert one somatic cell type, be it platelet, neuron, cardiac
myocyte, etc., and convert it into the cell type of their choice. iPSCs
can be generated from individuals of different genetic
backgrounds, including patients, and used in chemical screenings,
toxicology tests and other studies for the development of new
drugs. In addition, the ability to derive iPSCs from the same
individual means that these cells and the subsequently
differentiated target cells/tissues promise cell transplantation
therapies that reduce the risk of immune rejection. Furthermore, to
minimize the cost and time to prepare these cells, a number of
institutes in several countries, including Europe, the United States
and Japan, are working to establish iPS cell banks.
The 18th Takeda Science Foundation Symposium on Bioscience
will focus on “iPS Cells for Regenerative Medicine”, and the CiRA
International Symposium, which will be held on the second day as
part of the Takeda event, will consider “Pioneering Approaches to
iPSC-based Therapy”. Both programs will feature lectures on
state-of-the-art research in the iPSC field by distinguished speakers
from around the world.
On behalf of the organizing committee of the two symposia, we
cordially invite you to attend both to exchange expertise and ideas
and build relationships that will further promote this new and
exciting field.
We hope to see you in Osaka in January.
Organizing Committee
Organizing Committee
Shinya Yamanaka
CiRA, Kyoto University, Japan
Hideyuki Okano
Shinya Yamanaka
Hideyuki Okano
Keio University School of Medicine, Japan
Masayo Takahashi
Jun Takahashi
Masayo Takahashi
RIKEN Center for Developmental Biology, Japan
RIKEN Center for Developmental Biology, Japan
Keio University School of Medicine, Japan
Jun Takahashi
2
3
DIC:654
GENERAL INFORMATION
ACCESS MAP
Date and Site
Date:
January 15 - 17, 2015
MOMOYAMADAI
Sta.
(Satellite Workshop: January 14, 2015)
Site:
Minamisenri
Sta.
Center for Learning and Innovation (CLI),
Address: 50-2 Yamadaminami, Suita
Osaka 565-0823, Japan
Phone:
+81-6-6878-7712
Fax:
+81-6-6878-7740
KISHIBE
Sta.
Symposium Website: http://www.takeda-sci.com
Official Language
The official language of the symposium is English.
No simultaneous translation will be provided.
MOMOYAMADAI Sta.
KISHIBE
Sta.
Registration Desk opening hours
• Wednesday, January 14
• Thursday, January 15
• Friday, January 16
• Saturday, January 17
09:00 – 19:30
09:00 – 18:00
08:30 – 17:00
08:30 – 16:00
To Kobe
To Tokyo
Publication
A Program & Abstracts Book will be distributed to
all participants when registering.
Social events
All participants are cordially invited to the social events.
Site: Dining Hall “ODORIKO”, 1st Floor
Center for Learning and Innovation
• Wednesday, January 14
• Thursday, January 15
• Friday, January 16
Mini-reception
Welcome Reception
Banquet
Lunch
Lunch will be served at the Symposium site
on January 15 - 17.
17:30 – 19:15
18:30 – 20:00
18:00 – 19:30
Access to CLI:
Center for Learning and Innovation
Osaka Int’l Airport (Itami Airport, ITM)
Kansai Int’l Airport (KIX)
90 min. by JR
Airport Express, ‘HARUKA’
17 min. by Osaka Monorail
Osaka Monorail
Senrichuo Station
3 min. by
KIta-Osaka Kyuko Railway
KIta-Osaka Kyuko Railway
MOMOYAMADAI Station
JR Shin-Osaka Station
9 min. by JR
JR KISHIBE Station
10 min.-20 min. by bus.
HANKYU bus or FREE Shuttle bus
CLI
FREE Shuttle buses run from JR KISHIBE Station and
Kita-Osaka kyuko Railway MOMOYAMADAI Station.
A timetable will be available at the Symposium website.
http://www.takeda-sci.com
4
DIC:654
5
TIME TABLE
CB: Coffee Break
Thursday, January 15
Symposium Day 1
10:00
11:00
• Session 1: Neurological Disorders / Spinal Cord Injury
12:00
13:00
14:00
15:00
16:00
• Session 2: Regulation
17:00
18:00
19:00
20:00
Registration
(09:00-18:00)
Session 1
Session 1
(10:50-12:10)
(13:50-15:10)
Keynote (10:10-10:50)
Openinng Remarks (10:00-10:10)
Friday, January 16
09:00
Symposium Day 2
10:00
11:00
CB
Session 2
Welcome
Reception
(18:30-20:00)
Session 2
CB
(15:25-16:45)
(17:00-18:20)
Poster Session (12:50-13:50)
Lunch (12:10-12:50)
• Session 3: Parkinson's Disease / CiRA International Symposium
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
Registration
(08:30-17:00)
Session 3
(09:00-10:20)
CB
Session 3
(13:30-15:30)
(10:35-11:55)
Lunch (11:55-12:30)
Saturday, January 17
09:00
Symposium Day 3
10:00
11:00
Banquet
(18:00-19:30)
(15:45-17:45)
CB
• Session 4: Visual Impairment / Neurological Disorders • Session 5: Hematologic and Cardiac Diseases
12:00
13:00
14:00
15:00
16:00
17:00
Registration
(08:30-16:00)
Session 4
(09:00-10:20)
CB
Session 4
Session 5
(10:35-11:55)
(13:30-14:50)
CB
Session 5
(15:05-16:25)
Lunch (11:55-12:30)
Award Presentation Ceremony & Closing Remarks
(16:25-16:35)
Speakers
S2-1
Tatsuya Kondo
S3-1
Roger Barker
S4-1
Zaal Kokaia
S5-1
Deepak Srivastava
CiRA Int'l Symposium
S1-1
Hideyuki Okano
S2-2
Mahendra Rao
S3-2
Ole Isacson
S4-2
Jihwan Song
S5-2
Yoshiki Sawa
Qiao Joe Zhou
S1-2
Mark H. Tuszynski
S2-3
John Sinden
S3-3
Lorenz Studer
S4-3
Robin Ali
S5-3
Michel Sadelain
Atsushi Miyajima
S1-3
Steven Goldman
S2-4
Malcolm Moos
S3-4
Jun Takahashi
S4-4
Masayo Takahashi
S5-4
Koji Eto
Yoshiya Kawaguchi
S1-4
Nobuko Uchida
Keynote Shinya Yamanaka
Takanori Takebe
Shin Kaneko
Jun K. Yamashita
6
7
DIC:654
SYMPOSIUM PROGRAM
DAY 1 Thursday, January 15
10:00-10:10
Opening Remarks
Keynote Lecture
15:10-15:25
Coffee Break
Chairperson
Session 2
Deepak Srivastava Gladstone Institute of Cardiovascular Disease, U. S. A.
Regulation
10:10-10:50
Chairperson
iPS Cell Research in Regenerative Medicine
Masayo Takahashi RIKEN Center for Developmental Biology, Japan
Shinya Yamanaka CiRA, Kyoto University, Japan
15:25-16:05 S2-1
The PMDA’s challenge;Toward the world-leading
regenerative medical products in practice
Tatsuya Kondo PMDA, Japan
Session 1
Neurological disorders / Spinal cord injury
16:05-16:45 S2-2
Chairperson
Mahendra Rao New York Stem Cell Foundation(NYSCF), U. S. A.
Ole Isacson Harvard Medical School, U. S. A.
10:50-11:30 S1-1
Cell transplantation therapies for spinal cord injury focusing
on human iPS cells
Hideyuki Okano Keio University School of Medicine, Japan
11:30-12:10 S1-2
Neural Stem Cells in Models of Spinal Cord Injury
Mark H. Tuszynski University of California San Diego, U. S. A.
Making PSC derived products available: Issues and solutions
16:45-17:00
Coffee Break
17:00-17:40 S2-3
Stem cell therapies in Europe: Taking the CTX human neural
stem cell product to clinical trials in disabled stroke patients
John Sinden ReNeuron Limited, U. K.
17:40-18:20 S2-4
12:10-12:50
Lunch
12:50-13:50
Poster Session
TBA
Malcolm Moos FDA, U. S. A.
18:30-20:00
Welcome Reception
13:50-14:30 S1-3
Human glial progenitor cell-based treatment and modeling of
neurological disease
Steven Goldman University of Rochester, U. S. A.
14:30-15:10 S1-4
Biology and Translation of Human Neural Stem Cells, HuCNS-SC
Nobuko Uchida Stem Cells, Inc., U. S. A.
8
9
DIC:654
SYMPOSIUM PROGRAM
DAY 2 Friday, January 16
Session 3
Parkinson's disease
Chairperson
Chairperson
Jun Takahashi CiRA, Kyoto University, Japan
Hideyuki Okano Keio University School of Medicine, Japan
09:00-09:40 S3-1
How Can We Translate Stem Cell Based Therapies To
The Clinic In Parkinson's Disease? The Challenges Ahead.
Roger Barker University of Cambridge, U. K.
09:40-10:20 S3-2
The pre-clinical scientific evidence and rationale for iPS cell
and stem cell derived midbrain dopamine neuron
transplantation in Parkinson’s disease
Ole Isacson Harvard Medical School, U. S. A.
10:20-10:35
Coffee Break
13:30-14:10 CiRA-1
Regenerating insulin-secreting beta cells
with direct reprogramming
Qiao Joe Zhou Harvard Stem Cell Institute, U. S. A.
14:10-14:50 CiRA-2
Generation of functional pancreatic islets and
liver tissues from iPS cells
Atsushi Miyajima The University of Tokyo, Japan
14:50-15:30 CiRA-3
Generation of three-dimensional pancreatic tissue from
human pluripotent cells
Yoshiya Kawaguchi CiRA, Kyoto University, Japan
10:35-11:15 S3-3
Human pluripotent stem cell derived dopamine neurons for
cell therapy in Parkinson's disease
15:30-15:45
Lorenz Studer Memorial Sloan-Kettering Cancer Center, U. S. A.
15:45-16:25 CiRA-4
11:15-11:55 S3-4
Coffee Break
Realization of iPSC-organ bud transplantation therapy
Challenges towards stem cell therapy for Parkinson's disease
Takanori Takebe Yokohama City University School of Medicine, Japan
Jun Takahashi CiRA, Kyoto University, Japan
16:25-17:05 CiRA-5
Generation of immune cells from human iPS cells
11:55-12:30
Lunch
Shin Kaneko CiRA, Kyoto University, Japan
17:05-17:45 CiRA-6
12:30-13:30
Poster Session
Next-generation cardiac regenerative strategies using iPS
cells: 3D tissue engineering and new cell populations
Jun Yamashita CiRA, Kyoto University, Japan
18:00-19:30
10
Banquet
11
DIC:654
SYMPOSIUM PROGRAM
DAY 3 Saturday, January 17
Session 4
Session 5
Visual Impairment / Neurological disorders
Hematologic and cardiac diseases
Chairperson
Chairpersons
Steven Goldman University of Rochester, U. S. A.
Shin Kaneko CiRA, Kyoto University, Japan
Jun Yamashita CiRA, Kyoto University, Japan
09:00-09:40 S4-1
Induced pluripotent stem cells for ischemic stroke
13:30-14:10 S5-1
Zaal Kokaia Stem Cell Center, Lund University, Sweden
Reprogramming Approaches for Cardiovascular Disease
09:40-10:20 S4-2
Deepak Srivastava Gladstone Institute of Cardiovascular Disease, U. S. A.
iPSC-based cell therapy, disease modeling and
drug discovery in Huntington’s disease
14:10-14:50 S5-2
Jihwan Song CHA University, Korea
Yoshiki Sawa Osaka University, Japan
10:20-10:35
14:50-15:05
Coffee Break
iPS Cells for Regenerative Medicine
Coffee Break
10:35-11:15 S4-3
15:05-15:45 S5-3
Stem cell therapy for retinal degeneration: retinal repair by
photoreceptor transplantation
CAR T cell therapy and the promise of T cell engineering
Robin Ali UCL Institute of Ophthalmology, U. K.
Michel Sadelain Memorial Sloan-Kettering Cancer Center, U. S. A.
15:45-16:25 S5-4
11:15-11:55 S4-4
Challenge of Large Scale Production by iPS cell-platelets
Application of iPS cells to retinal disease
Koji Eto CiRA, Kyoto University, Japan
Masayo Takahashi RIKEN Center for Developmental Biology, Japan
11:55-12:30
Lunch
12:30-13:30
Poster Session
12
16:25-16:35
Award Presentation Ceremony
and Closing Remarks
13
DIC:654

iPS Cells for Regenerative Medicine CiRA International Symposium

Transcription

Similar documents